Selected Tag: Natco Pharma

Selected Tag: Natco Pharma

Lupin and Natco Launch Generic Bosentan in US with 180-Day Exclusivity

BasisPoint Insight

August 21, 2025 at 2:44 AM IST

Natco Pharma April-June Net Profit Falls 28% On Year to ₹4.81 Billion

BasisPoint Insight

August 12, 2025 at 10:24 AM IST

NATCO Pharma to Invest ₹41 Billion in South Africa Expansion

BasisPoint Insight

July 25, 2025 at 4:13 AM IST

US FDA Issues 7 Observations To Natco Pharma’s Kothur Unit

BasisPoint Insight

June 20, 2025 at 9:21 AM IST

Natco Pharma Gets One USFDA Observation For Hyderabad API unit

BasisPoint Insight

June 16, 2025 at 9:39 AM IST

Natco Pharma January-March Profit Rises 5% But Misses Estimates; Revenue Up 14%

BasisPoint Insight

May 30, 2025 at 9:08 AM IST

Natco’s Cut-Price Cure Has A Premium Twist

A complex drug priced 99.9% below the original might just lift this stock’s value perception.

Dev Chandrasekhar

April 9, 2025 at 5:26 AM IST

Article related image

iStock.com/Rawf8

Natco Pharma To Price Generic Risdiplam At ₹15,900 In India

BasisPoint Insight

April 8, 2025 at 7:19 AM IST

The Bureau

Asian Equities Gain on Fed Cut Bets, but Global Political Risks Keep Markets Cautious

Moody’s Warns AI Could Redefine Sovereign and Corporate Credit by 2030

GST Overhaul Seen Adding 0.7-0.8% to GDP this Year

Setting the Record Straight on Trump’s India Rant

Nominal Weakness Tells the Real Story for RBI

Setback for Trump Tariffs in US Court, Hope for Traders

India Bets on SCO to Blunt the Edge of US Tariffs and Sanctions

India’s Economy Expands 7.8% in June Quarter, Highest in Five Quarters

Nepal in Crisis | Saibal Dasgupta and Dr. Pramod Jaiswal

Sarci-Sense: About Silent Goodbyes & How Middle-Age Friendships Disappear

iStock.com